124 related articles for article (PubMed ID: 10607872)
21. The selective endothelin ETA receptor antagonist FR139317 inhibits neointimal thickening in the rat.
Takiguchi Y; Sogabe K
Eur J Pharmacol; 1996 Aug; 309(1):59-62. PubMed ID: 8864694
[TBL] [Abstract][Full Text] [Related]
22. ET-1 receptor gene expression and distribution in L1 and L2 cells from hypertensive sheep pulmonary artery.
Balyakina EV; Chen D; Lawrence ML; Manning S; Parker RE; Shappell SB; Meyrick B
Am J Physiol Lung Cell Mol Physiol; 2002 Jul; 283(1):L42-51. PubMed ID: 12060559
[TBL] [Abstract][Full Text] [Related]
23. Renal vascular effects of the selective endothelin receptor antagonists in anaesthetized rats.
Matsuura T; Miura K; Ebara T; Yukimura T; Yamanaka S; Kim S; Iwao H
Br J Pharmacol; 1997 Sep; 122(1):81-6. PubMed ID: 9298531
[TBL] [Abstract][Full Text] [Related]
24. Endothelin receptor blockade prevents the rise in pulmonary vascular resistance after cardiopulmonary bypass in lambs with increased pulmonary blood flow.
Petrossian E; Parry AJ; Reddy VM; Akkersdijk GP; McMullan DM; Thompson L; Hendricks-Munoz KD; Hallak H; Hanley FL; Fineman JR
J Thorac Cardiovasc Surg; 1999 Feb; 117(2):314-23. PubMed ID: 9918974
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of endothelin-1 and hypoxia-induced pulmonary pressor responses in the rat by a novel selective endothelin-A receptor antagonist, di-n-butylaminocarbamyl-L-leucyl-D-tryptophanyl-D-4-chloro-Phe.
Yan LD; Kong LL; Yong Z; Dong HJ; Chi MG; Pan XF; Zhang C; Liang YJ; Gong ZH; Liu KL
J Cardiovasc Pharmacol; 2010 Sep; 56(3):246-54. PubMed ID: 20531217
[TBL] [Abstract][Full Text] [Related]
26. Depressor responses to endothelin-1 into the superior colliculus of rats: predominant role of endothelin ET(B) receptors.
D'Amico M; Di Filippo C; Rossi F
Eur J Pharmacol; 1998 Apr; 347(1):71-5. PubMed ID: 9650850
[TBL] [Abstract][Full Text] [Related]
27. Endothelin-A receptor antagonist prevents acute hypoxia-induced pulmonary hypertension in the rat.
Oparil S; Chen SJ; Meng QC; Elton TS; Yano M; Chen YF
Am J Physiol; 1995 Jan; 268(1 Pt 1):L95-100. PubMed ID: 7840234
[TBL] [Abstract][Full Text] [Related]
28. Improvement of renal dysfunction in dogs with endotoxemia by a nonselective endothelin receptor antagonist.
Mitaka C; Hirata Y; Yokoyama K; Nagura T; Tsunoda Y; Amaha K
Crit Care Med; 1999 Jan; 27(1):146-53. PubMed ID: 9934909
[TBL] [Abstract][Full Text] [Related]
29. Nonpeptide endothelin receptor antagonists. VIII: attentuation of acute hypoxia-induced pulmonary hypertension in the dog.
Willette RN; Ohlstein EH; Mitchell MP; Sauermelch CF; Beck GR; Luttmann MA; Hay DW
J Pharmacol Exp Ther; 1997 Feb; 280(2):695-701. PubMed ID: 9023281
[TBL] [Abstract][Full Text] [Related]
30. The hemodynamic effects of endothelin receptor antagonism during a venous air infusion in dogs.
Tanus-Santos JE; Gordo WM; Udelsmann A; Moreno H
Anesth Analg; 2000 Jan; 90(1):102-6. PubMed ID: 10624986
[TBL] [Abstract][Full Text] [Related]
31. Cardiovascular responses mediated by two types of endothelin ET(B) receptor in spontaneously hypertensive and Wistar-Kyoto rats.
Kuwahara M; Masuda T; Tsubone H; Sugano S; Karaki H
Eur J Pharmacol; 1996 Jan; 296(1):55-63. PubMed ID: 8720477
[TBL] [Abstract][Full Text] [Related]
32. Role of endogenous endothelins in catecholamine secretion in the rat adrenal gland.
Nagayama T; Kuwakubo F; Matsumoto T; Fukushima Y; Yoshida M; Suzuki-Kusaba M; Hisa H; Matsumura Y; Kimura T; Satoh S
Eur J Pharmacol; 2000 Oct; 406(1):69-74. PubMed ID: 11011035
[TBL] [Abstract][Full Text] [Related]
33. Effect of combination of a tissue-type plasminogen activator and an endothelin receptor antagonist, FR139317, in the rat cerebral infarction model.
Umemura K; Ishiye M; Kosuge K; Nakashima M
Eur J Pharmacol; 1995 Feb; 275(1):17-21. PubMed ID: 7774658
[TBL] [Abstract][Full Text] [Related]
34. Effects of endothelin receptor A antagonist FR139317 on rats with congestive heart failure.
Chen XC; Zhang XM; Luo NS; Fang C; Liu YM; Wu W
Acta Pharmacol Sin; 2001 Oct; 22(10):896-900. PubMed ID: 11749771
[TBL] [Abstract][Full Text] [Related]
35. Pulmonary hypertension secondary to left ventricular dysfunction: the role of nitric oxide and endothelin-1 in the control of pulmonary vascular tone.
Deuchar GA; Docherty A; MacLean MR; Hicks MN
Br J Pharmacol; 2002 Feb; 135(4):1060-8. PubMed ID: 11861335
[TBL] [Abstract][Full Text] [Related]
36. Dual endothelin receptor blockade with tezosentan markedly attenuates hypoxia-induced pulmonary vasoconstriction in a porcine model.
Hedelin P; Kylhammar D; Rådegran G
Acta Physiol (Oxf); 2012 Mar; 204(3):419-34. PubMed ID: 21726419
[TBL] [Abstract][Full Text] [Related]
37. Role of endothelin-1 in beagles with dehydromonocrotaline-induced pulmonary hypertension.
Okada M; Yamashita C; Okada M; Okada K
Circulation; 1995 Jul; 92(1):114-9. PubMed ID: 7788905
[TBL] [Abstract][Full Text] [Related]
38. Endothelin mediates increased pulmonary vascular tone in patients with heart failure: demonstration by direct intrapulmonary infusion of sitaxsentan.
Ooi H; Colucci WS; Givertz MM
Circulation; 2002 Sep; 106(13):1618-21. PubMed ID: 12270852
[TBL] [Abstract][Full Text] [Related]
39. Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels.
Seo B; Oemar BS; Siebenmann R; von Segesser L; Lüscher TF
Circulation; 1994 Mar; 89(3):1203-8. PubMed ID: 8124808
[TBL] [Abstract][Full Text] [Related]
40. Endothelin A receptor blockade decreases pulmonary vascular resistance in premature lambs with hyaline membrane disease.
Ivy DD; Parker TA; Kinsella JP; Abman SH
Pediatr Res; 1998 Aug; 44(2):175-80. PubMed ID: 9702910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
